Clinical Trial Update: CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma [Phase 4]

View source ↗

Summary

Phase 4 results update on using the CEV chemotherapy regimen with or without periocular carboplatin for extraocular retinoblastoma. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Vincristine (vincristine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinoblastoma | Phase 4 | Status: COMPLETED | Results posted: 2015-03-30